Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

Hip Fracture Clinical Trial

Official title:

Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00162630
• Other study ID #: HHSG-rct-04
• Status: Completed
• Phase: Phase 4
• First received: September 8, 2005
• Last updated: September 13, 2006
• Start date: May 2003
• Est. completion date: March 2006

Study information

• Verified date: September 2006
• Source: Hvidovre University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: National Board of Health
• Study type: Interventional

Clinical Trial Summary

To evaluate the analgesic potential of an neural blockade (Fascia iliaca compartment) with local anaesthetics in patients with hip fracture immediately after arrival in the emergency department.

Description:

Hip fracture patients have severe pain in the acute phase. Traditional analgesic treatment have consisted of intramuscular morphine with its associated side effects. The trial evaluates the Fascia iliaca compartment compared to regular opioid pain therapy in hip fracture patinets immediately after arrival at the emergency department.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 48
• Est. completion date: March 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Primary hip fracture suspected

• able to give informed consent

• no substance abuse

• no regular opioid therapy

• no opioid treatment within the last 6 hours

• morphine intolerance

• allergies to local anaesthetics

Exclusion Criteria:

• Fracture ruled out on x-ray

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Fractures, Bone
• Hip Fracture
• Hip Fractures

Intervention

Procedure:
• Fascia Iliaca Compartment Blockade

Locations

Country	Name	City	State
Denmark	Hvidovre University Hospital	Hvidovre

Sponsors (2)

Lead Sponsor	Collaborator
Hvidovre University Hospital	IMK Fonden

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain relief within 3 hours
Secondary	Nausea
Secondary	Pain on transfer
Secondary	Discomfort with block placement